$KRRO
Korro Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.80
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKorro Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is KRRO up today? It is at $11.80 (+0.00%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KRRO spikes, and full due diligence on KRRO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KRRO 16 times in the last 30 days. Create a free account to track $KRRO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on KRRO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KRRO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Formela Jean Francois Director | Sold (automatic/other) | -38K 0.3% of company | sold 4.7% | 773K | $543K at $14.12 | Sep 14, 26 |
Dolan Oliver Officer | Sold (automatic/other) | -5 | sold <0.1% | 16K | $69 at $13.72 | Sep 11, 26 |
Formela Jean Francois Director | Sold (automatic/other) | -10K 0.07% of company | sold 6.8% | 139K | $143K at $13.99 | Sep 11, 26 |
Dolan Oliver Officer | Sold (automatic/other) | -6 | sold <0.1% | 16K | $82 at $13.60 | Sep 9, 26 |
Dolan Oliver Officer | Sold (automatic/other) | -7K 0.05% of company | sold 31% | 16K | $99K at $13.51 | Sep 8, 26 |
Formela Jean Francois Director | Sold (automatic/other) | -300 | sold <0.1% | 822K | $4K at $13.96 | Aug 26, 26 |
Formela Jean Francois Director | Sold (automatic/other) | -28K 0.2% of company | sold 3.3% | 822K | $399K at $14.00 | Aug 19, 26 |
Formela Jean Francois Director | Sold (automatic/other) | -2K 0.01% of company | sold 0.3% | 851K | $30K at $13.96 | Aug 11, 26 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +1K | added <0.1% | 1.54M | $19K at $13.19 | Aug 10, 26 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +5K 0.04% of company | added 0.3% | 1.54M | $60K at $11.40 | Aug 6, 26 |
Aiyar Ram Officer | Sold (automatic/other) | -6K 0.04% of company | sold 7.8% | 69K | $63K at $10.84 | Aug 4, 26 |
Chappell Todd Officer | Acquired (grant/award) | +8K 0.05% of company | added 44% | 24K | n/a | Jul 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on KRRO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KRRO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
KRRO last traded at $11.80, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Korro Bio, Inc. Common Stock (KRRO) is next expected to report earnings on Wednesday, November 11, 2026, about 54 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KRRO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KRRO 16 times in the last 30 days.
KRRO (Korro Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $204M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KRRO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KRRO discussion
Sign in to ask a question or join the discussion.